🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 6 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/01/2026 86,54 88,16 85,19 87,18 -0,18% 3,43% 751.700
31/12/2025 87,32 88,23 85,98 87,34 +0,09% 2,58% 615.700
30/12/2025 87,94 88,32 86,12 87,26 -0,76% 2,50% 344.000
29/12/2025 88,66 89,10 87,30 87,93 -0,96% 2,03% 373.100
26/12/2025 88,78 89,61 87,47 88,78 -0,07% 2,41% 390.100
24/12/2025 88,53 89,47 87,47 88,84 +0,12% 2,26% 154.100
23/12/2025 87,27 90,00 87,27 88,73 +1,51% 3,13% 329.100
22/12/2025 85,33 88,13 84,88 87,41 +1,58% 3,81% 661.100
19/12/2025 86,58 87,73 84,81 86,05 +0,30% 3,37% 1.736.500
18/12/2025 89,35 90,02 84,11 85,79 -3,97% 6,61% 2.227.500
17/12/2025 91,41 92,54 88,38 89,34 -2,40% 4,55% 821.600
16/12/2025 93,93 94,54 90,18 91,54 -3,43% 4,64% 881.100
15/12/2025 95,41 96,54 94,17 94,79 -0,59% 2,48% 960.000
12/12/2025 92,72 95,39 91,70 95,35 +3,36% 3,98% 1.286.800
11/12/2025 92,01 93,07 91,07 92,25 +0,95% 2,17% 800.700
10/12/2025 88,56 91,96 88,34 91,38 +3,18% 4,09% 1.308.400
09/12/2025 89,73 92,80 88,30 88,56 -1,87% 5,02% 1.440.000
08/12/2025 90,94 91,89 89,51 90,25 +0,67% 2,62% 1.455.800
05/12/2025 87,96 90,18 87,54 89,65 +2,66% 3,00% 1.473.100
04/12/2025 86,07 88,10 85,13 87,33 +1,46% 3,45% 736.800
03/12/2025 85,43 87,10 84,73 86,07 +1,68% 2,77% 715.200
02/12/2025 85,75 86,39 83,52 84,65 -1,16% 3,35% 992.800
01/12/2025 89,61 89,85 85,00 85,64 -4,84% 5,41% 999.700
28/11/2025 90,00 90,46 88,78 90,00 -0,08% 1,87% 337.400
26/11/2025 90,00 90,85 89,50 90,07 +0,23% 1,50% 1.205.200
25/11/2025 88,46 89,88 87,76 89,86 +2,47% 2,40% 910.900
24/11/2025 86,59 88,34 85,71 87,69 +2,68% 3,03% 872.400
21/11/2025 84,24 86,67 83,64 85,40 +1,43% 3,60% 907.100
20/11/2025 86,36 86,95 84,00 84,20 -1,09% 3,42% 789.500
19/11/2025 84,54 86,65 84,45 85,13 +0,88% 2,60% 989.300